Skip to main content
Log in

Validation of a Persian version of the Fibromyalgia Impact Questionnaire (FIQ-P)

  • Original Article
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

The aim of this study is to translate, adapt, and validate a Persian version of the Fibromyalgia (FM) Impact Questionnaire (FIQ-P). The FIQ-P was adapted following the translation and back-translation approach; then, it was administered to thirty females with FM. Participants also completed two other validated questionnaires, the Medical Outcome Survey Short Form-36 (SF-36) and the Beck Depression Inventory (BDI). Internal consistency within the FIQ-P items and its test–retest reliability were assessed with Cronbach’s alpha and Spearman’s correlation coefficient, respectively. Construct validity was analyzed by Spearman’s r when correlating the FIQ-P to other questionnaires. The translated version was concordant. Adaptation affected two sub-items of physical function. Participants’ mean age ± standard deviation was 40.4 ± 9.0 years. Internal consistency proved good with α = 0.80. Test–retest coefficient ranged from 0.50 for the item “work days missed” to 0.79 for all FIQ-P items. Fair and statistically significant (P < 0.01) correlations were found between the FIQ-P items and two other questionnaires, SF-36 (r = −0.57) and BDI (r = 0.53). We concluded that the FIQ-P is a valid and reliable instrument for measuring health status of Persian-speaking FM patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Crofford LJ (2011) Fibromyalgia. In: Longo DLFA, Kasper D, Hauser S, Jameson J, Loscalzo J (eds) Harrison’s principles of internal medicine, 18th edn. McGraw-Hill Companies, New York

    Google Scholar 

  2. Bidari A, Ghavidel-Parsa B, Ghalehbaghi B (2009) Reliability of ACR criteria over time to differentiate classic fibromyalgia from nonspecific widespread pain syndrome: a 6-month prospective cohort study. Mod Rheumatol 19:663–669

    PubMed  Google Scholar 

  3. Yunus MB (1992) Towards a model of pathophysiology of fibromyalgia: aberrant central pain mechanisms with peripheral modulation. J Rheumatol 19(6):846–850

    CAS  PubMed  Google Scholar 

  4. Bennett RM (1999) Emerging concepts in the neurobiology of chronic pain: evidence of abnormal sensory processing in fibromyalgia. Mayo Clin Proc 74(4):385–398

    Article  CAS  PubMed  Google Scholar 

  5. Granges G, Littlejohn G (1993) Pressure pain threshold in pain-free subjects, in patients with chronic regional pain syndromes, and in patients with fibromyalgia syndrome. Arthritis Rheum 36(5):642–646

    Article  CAS  PubMed  Google Scholar 

  6. Yunus MB, Ahles TA, Aldag JC, Masi AT (1991) Relationship of clinical features with psychological status in primary fibromyalgia. Arthritis Rheum 34:15–21

    Article  CAS  PubMed  Google Scholar 

  7. Bidari A, Hassanzadeh M, Ghavidel-Parsa B, Kianmehr N, Kabir A, Pirhadi S, et al (2013) Validation of the 2010 American Colleague of Rheumatology preliminary diagnostic criteria for fibromyalgia in an Iranian population. Rheumatol Int [Epub ahead of print]

  8. Hughes G, Martinez C, Myon E et al (2006) The impact of a diagnosis of fibromyalgia on health care resource use by primary care patients in the UK: an observational study based on clinical practice. Arthritis Rheum 54:177

    Article  PubMed  Google Scholar 

  9. Mease P, Arnold L (2009) Fibromyalgia syndrome module in OMERACT 9: domain construct. J Rheumatol 36(11):2318–2329

    Article  PubMed Central  PubMed  Google Scholar 

  10. White KP, Harth M (1996) An analytical review of 24 controlled clinical trials for fibromyalgia syndrome (FMS). Pain 64:211–219

    Article  CAS  PubMed  Google Scholar 

  11. Meenan RF, Gertman PM, Mason JH (1980) Measuring health status in arthritis. The arthritis impact measurement scales. Arthritis Rheum 23:146–152

    Article  CAS  PubMed  Google Scholar 

  12. Fries JF, Spitz P, Kraines RG, Holman HR (1980) Measurement of patient outcome in arthritis. Arthritis Rheum 23:137–145

    Article  CAS  PubMed  Google Scholar 

  13. Ware JJ, Sherbourne C (1992) The MOS 36-Item Short-Form Health Survey (SF-36). Med Care 30:473–483

    Article  PubMed  Google Scholar 

  14. Burckhardt CS, Clark SR, Bennett RM (1991) The fibromyalgia impact questionnaire: development and validation. J Rheumatol 18:728–733

    CAS  PubMed  Google Scholar 

  15. Hawley DJ, Wolfe F (1991) Pain, disability, and pain/disability relationships in seven rheumatic disorders: a study of 1,522 patients. J Rheumatol 18:1552–1557

    CAS  PubMed  Google Scholar 

  16. Wolfe F, Ross K, Anderson J, Russell IJ (1995) Aspects of fibromyalgia in the general population: sex, pain threshold, and fibromyalgia symptoms. J Rheumatol 22:151–156

    CAS  PubMed  Google Scholar 

  17. El-Naby MA, Hefny MA, Fahim AE, Awadalla MA et al (2013) Validation of an adapted Arabic version of fibromyalgia syndrome impact questionnaire. Rheumatol Int 33(10):2561–2567

    Article  PubMed  Google Scholar 

  18. Zijlstra TR, Taal E, van de Laar MA, Rasker JJ (2007) Validation of a Dutch translation of the fibromyalgia impact questionnaire. Rheumatology (Oxford) 46:131–134

    Article  CAS  Google Scholar 

  19. Perrot S, Dumont D, Guillemin F, Pouchot J, Coste J (2003) Quality of life in women with fibromyalgia syndrome: validation of the QIF, the French version of the fibromyalgia impact questionnaire. J Rheumatol 30:1054–1059

    PubMed  Google Scholar 

  20. Offenbaecher M, Waltz M, Schoeps P (2000) Validation of a German version of the Fibromyalgia Impact Questionnaire (FIQ-G). J Rheumatol 27:1984–1988

    CAS  PubMed  Google Scholar 

  21. Sarzi-Puttini P, Atzeni F, Fiorini T, Panni B, Randisi G, Turiel M, Carrabba M (2003) Validation of an Italian version of the Fibromyalgia Impact Questionnaire (FIQ-I). Clin Exp Rheumatol 21:459–464

    CAS  PubMed  Google Scholar 

  22. Osada K, Oka H, Isomura T, Nakamura I, Tominaga K, Takahashi S, Kojima A, Nishioka K (2011) Development of the Japanese version of the Fibromyalgia Impact Questionnaire (JFIQ): psychometric assessments of reliability and validity. Int J Rheum Dis 14(1):74–80

    Article  PubMed  Google Scholar 

  23. Rivera J, Gonzalez T (2004) The Fibromyalgia Impact Questionnaire. A validated Spanish version to assess the health status in women with fibromyalgia. Clin Exp Rheumatol 22:554–560

    CAS  PubMed  Google Scholar 

  24. Hedin PJ, Hamne M, Burckhardt CS, Engstrom-Laurent A (1995) The Fibromyalgia Impact Questionnaire, a Swedish translation of a new tool for evaluation of the fibromyalgia patient. Scand J Rheumatol 24:69–75

    Article  CAS  PubMed  Google Scholar 

  25. Kim YA, Lee SS, Park K (2002) Validation of a Korean version of the fibromyalgia impact questionnaire. J Korean Med Sci 17:220–224

    PubMed Central  PubMed  Google Scholar 

  26. Sarmer S, Ergin S, Yavuzer G (2000) The validity and reliability of the Turkish version of the Fibromyalgia Impact Questionnaire. Rheumatol Int 20:9–12

    Article  CAS  PubMed  Google Scholar 

  27. Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL et al (1990) The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 33(2):160–172

    Article  CAS  PubMed  Google Scholar 

  28. Motamed N, Ayatollahi AR, Zare N, Sadeghi-Hassanabadi A (2005) Validity and reliability of the Persian translation of the SF-36 version 2 questionnaire. East Mediterr Health J 11(3):349–357

    CAS  PubMed  Google Scholar 

  29. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J (1961) An inventory for measuring depression. Arch Gen Psychiatry 4:53–63

    Article  Google Scholar 

  30. Ghassemzadeh H, Mojtabai R, Karamghadiri N, Ebrahimkhani N (2005) Psychometric properties of a Persian-language version of the Beck Depression Inventory, second edition: BDI-II-PERSIAN. Depress Anxiety 21(4):185–192

    Article  PubMed  Google Scholar 

  31. Wolfe F, Hawley DJ, Goldenberg DL, Russell IJ, Buskila D, Neumann L (2000) The assessment of functional impairment in fibromyalgia (FM): Rasch analyses of 5 functional scales and the development of the FM Health Assessment Questionnaire. J Rheumatol 27(8):1989–1999

    CAS  PubMed  Google Scholar 

  32. Bennett R (2005) The Fibromyalgia Impact Questionnaire (FIQ): a review of its development, current version, operating characteristics and uses. Clin Exp Rheumatol 23(Suppl. 39):S154–S162

    CAS  PubMed  Google Scholar 

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Effat Merghati Khoei.

Appendix: Persian version of Fibromyalgia Impact Questionnaire (FIQ-P)

Appendix: Persian version of Fibromyalgia Impact Questionnaire (FIQ-P)

figure a
figure b
figure c

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bidari, A., Hassanzadeh, M., Mohabat, MF. et al. Validation of a Persian version of the Fibromyalgia Impact Questionnaire (FIQ-P). Rheumatol Int 34, 181–189 (2014). https://doi.org/10.1007/s00296-013-2883-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-013-2883-0

Keywords

Navigation